Anti-Microglobulin ß2, Recombinant [BBM.1]
Invented by Prof Walter Bodmer from University of Oxford
Invented at University of Oxford
- Datasheet
- References (1)
- Inventor Info
Info
| Catalogue Number | 153361 |
| Applications | FACS IHC IP Fn |
| Antigen/Gene or Protein Targets | Microglobulin Beta 2 |
| Reactivity | Human |
| Relevance | Beta2-microglobulin associates with human leucocyte antigens (HLAs). BBM.1 binds significantly with fibroblasts and lymphocytes from humans and primates and can be used for the detection of Beta2-microglobulin in myeloma and other conditions (serum assay kits etc.). BBM.1 binds equivalently to free and HLA-associated Beta2-microglobulin and may be used for detection in myeloma and other conditions (e.g. within serum assay kits). |
| Host | Mouse |
| Immunogen | Molt 4, a human T cell line. |
| Subclass | IgG2b |
| Formulation | PBS |
| Concentration | 1mg/ml |
| Research Area | Cancer, Cardiovascular |
| Notes | Recombinant monoclonal antibody produced from the original monoclonal. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma. |
References: 1 entry
Original hybridoma first published in: Brodsky et al. 1979. Eur J Immunol. 9(7):536-45. PMID: 91522.
Add a reference
References: 1 entry
Original hybridoma first published in: Brodsky et al. 1979. Eur J Immunol. 9(7):536-45. PMID: 91522.
Add a reference
